Evidence map›Paper›PMID 39763873›Full record

ArticlebioRxiv : the preprint server for biology2025

A deep learning method for predicting interactions for intrinsically disordered regions of proteins.

Kartik Majila, Varun Ullanat, Shruthi Viswanath

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Kartik MajilaNational Center for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India 560065.ORCID 0009-0006-3190-7977
Varun UllanatNational Center for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India 560065.ORCID 0000-0002-1238-7041
Shruthi ViswanathNational Center for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India 560065.ORCID 0000-0002-9061-8407

Funding

XRAY CRYSTALLOGRAPHIC STRUCTURE ANALYSIS: PROTEIN SORTINGP41RR001081 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COHEN, BRUCE E · 1985 to 2011
$17.6M
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
NCRR NIH HHS P41 RR001081NIGMS NIH HHS R01 GM129325
6 · The paper itself

Abstract

Intrinsically disordered proteins or regions (IDPs/IDRs) adopt diverse binding modes with different partners, from coupled-folding-and-binding, to fuzzy binding, to fully-disordered binding. Characterizing IDR interfaces is challenging experimentally and computationally. The state-of-the-art AlphaFold-multimer and AlphaFold3 can be used to predict IDR binding sites, although they are less accurate at their benchmarked confidence cutoffs. Here, we developed Disobind, a deep-learning method that predicts inter-protein contact maps and interface residues for an IDR and its partner, given their sequences. It uses sequence embeddings from the ProtT5 protein language model. Disobind outperforms state-of-the-art interface predictors for IDRs. It also outperforms AlphaFold-multimer and AlphaFold3 at multiple confidence cutoffs. Combining Disobind and AlphaFold-multimer predictions further improves the performance. In contrast to current methods, Disobind considers the context of the binding partner and does not depend on structures and multiple sequence alignments. Its predictions can be used to localize IDRs in large assemblies and characterize IDR-mediated interactions.

Indexed as

deep learning (DL)Intrinsically disordered proteins (IDP)intrinsically disordered regions (IDR)protein language model (pLMs)protein structure

Identifiers

PMID39763873
PMCPMC11702703

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.